In partnership with Gilead Sciences and The University of Queensland (UQ) Poche Centre for Indigenous Health, today we unveil the Guiding Local Opportunities for Wellbeing (GLOWS) Indigenous Health Grant Program, a new $4.4M, three-year initiative to support Aboriginal and Torres Strait Islander communities in their efforts toward elimination of HIV and viral hepatitis.
The program offers scholarships and research grants to Aboriginal and Torres Strait Islander community organisations and their partners for work relating to HIV and viral hepatitis over the next three years.
Despite advancements in HIV and viral hepatitis, the rates of diagnosis are disproportionately higher in Aboriginal and Torres Strait Islander communities compared with the non-Indigenous population. In 2022 rates of hepatitis C notifications were seven times greater among the Aboriginal and Torres Strait Islander communities compared with the non-Indigenous population (156.2 compared to 21.7 per 100,000). Additionally, HIV notification rate for Aboriginal and Torres Strait Islander communities was 1.3 times the rate for the non-Indigenous population (4.9 compared to 3.8 per 100,000).